Vaxart, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Vaxart, Inc. has filed 1,743 SEC EDGAR filings since 08 Nov 1994

SEC filing history

Showing 926-950 of 1,000 matching filings.

Per page
25
Current page
38
8-K File 001-35285

FORM 8-K

Filing date
14 Jun 2012
Reporting date
08 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
PREM14A File 001-35285

PRELIMINARY PROXY STATEMENT

Filing date
08 Jun 2012
Reporting date
08 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35285

SOLICITING MATERIAL

Filing date
10 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35285

SOLICITING MATERIALS

Filing date
10 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35285

FORM 8-K

Filing date
10 May 2012
Reporting date
10 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-31596

SC 13G filing

Filing date
02 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35285

SOLICITING MATERIALS

Filing date
01 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-35285

FORM 10-K AMENDMENT

Filing date
30 Apr 2012
Reporting date
31 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35285

FORM 8-K

Filing date
26 Apr 2012
Reporting date
20 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35285

FORM 8-K

Filing date
26 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35285

SOLICITING MATERIALS

Filing date
25 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35285

SOLICITING MATERIALS

Filing date
24 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35285

FORM 8-K

Filing date
23 Apr 2012
Reporting date
22 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35285

FORM 8-K

Filing date
23 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35285

FORM 8-K

Filing date
23 Apr 2012
Reporting date
23 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35285

FORM 8-K

Filing date
23 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Apr 2012
Reporting date
05 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35285

FORM 8-K

Filing date
14 Mar 2012
Reporting date
14 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-31596

SCHEDULE 13G/A FOR NABI BIOPHARMACEUTICALS

Filing date
14 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-31596

SC 13G/A filing

Filing date
13 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-31596

13G/A

Filing date
13 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-31596

SC 13G/A filing

Filing date
08 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-31596

SC 13D/A filing

Filing date
13 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .